Thin Film Electronics ASA
Thin Film Electronics ASA - Warrant Exercise
Oslo, 6 January 2021
Reference is made to the announcement by Thin Film Electronics ASA (the "Company") on 20 May 2020 regarding an Extraordinary General Meeting where the shareholders resolved to issue warrants to participants in a Private Placement and Subsequent Offering of shares, and on 30 June 2020 regarding the result of the Subsequent Offering.
Since the warrant exercises announced on 18 December 2020, the Company has received further notices of exercise of a total of 41,480,126 Warrants A and a total of 1,072,573 Warrants B, and has subsequently resolved to increase the Company's share capital by NOK 4,680,796.89 in connection with the issuance of shares upon said exercises.
Upon registration of this share capital increase, the Company's share capital will be NOK 114,535,205.84 divided into 1,041,229,144 shares, each share having a par value of NOK 0.11.
Kevin Barber - Chief Executive Officer
This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Thin Film Electronics ASA26.1.2021 18:03:44 CET | Press release
Thin Film Electronics ASA - Registration of Share Capital Increase
IPSOS26.1.2021 18:02:44 CET | Press release
Ipsos consolidates its Out-of-home measurement leadership with the acquisition of MGE Data
SOLUTIONS 3026.1.2021 18:01:44 CET | Press release
Solutions 30 : REMARKABLE REVENUE GROWTH IN 2020
EXEL INDUSTRIES26.1.2021 18:01:33 CET | Press release
Exel Industries :First quarter 2020-2021 revenue : A promising first quarter: 19% growth
NACON26.1.2021 17:46:33 CET | Press release
PRESS RELEASE: NACON AND DAEDALIC ENTERTAINMENT ARE FORMING A FELLOWSHIP TO PUBLISH AND DISTRIBUTE THE HIGHLY-ANTICIPATED THE LORD OF THE RINGS: GOLLUM
NTG Nordic Transport Group A/S26.1.2021 17:16:21 CET | Press release
Transactions in connection with share buyback program
Junshi Biosciences26.1.2021 16:37:10 CET | Press release
New data show treatment with etesevimab (JS016) and bamlanivimab together reduced risk of COVID-19 hospitalizations and death by 70 percent
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom